Clinical characteristics of S. maltophilia bacteraemic patients compared to P. aeruginosa and Acinetobacter species bacteraemic patients: univariate analysis.

SM, S. maltophilia; PA, P. aeruginosa; AC, Acinetobacter species; IQR, interquartile range; SOFA, Sequential Organ Failure Assessment; CRRT, continuous renal replacement therapy; ICU, Intensive care unit; TMP-SMZ, trimethoprim-sulfamethoxazole.aAll of the patients other than those with nosocomial bacteraemia had underlying comorbidities and had been followed up in the outpatient department.bAntipseudomonal cephalosporins or carbapenems were administered in 13 patients (76.4%).cAntipseudomonal cephalosporins or carbapenems were administered in 26 patients (89.6%).dAll of these patients received TMP-SMZ for prophylaxis against Pneumocystis jirovecii pneumonia.eMicrobiological examinations were performed in 48 patients (88.9%) in the SM group, in 120 patients (71.9%) in the PA group, and in 48 patients (69.6%) in the AC group. The percentages in the Table represent the number of patients with SM isolation divided by the number of patients who underwent microbiological examination.Clinical characteristics of S. maltophilia bacteraemic patients compared to P. aeruginosa and Acinetobacter species bacteraemic patients: univariate analysis.